Congruence and Ono Announce Multi-Target Research Collaboration to Generate Small Molecule Correctors for the Treatment of Cancer
Collaboration leverages Congruence's proprietary drug discovery engine, Revenir™ Congruence to receive an undisclosed upfront payment and is eligible to receive...
